1,8,15,22-Tetrazacyclooctacosane-2,7,16,21-tetraone
CAS: 4238-35-1
Ref. 3D-EAA23835
| 1mg | 381.00 € | ||
| 2mg | 542.00 € | ||
| 5mg | 904.00 € | ||
| 10mg | 1,215.00 € | ||
| 25mg | 2,429.00 € |
Product Information
1,8,15,22-Tetrazacyclooctacosane-2,7,16,21-tetraone is an inhibitor with potent anticancer properties. It induces apoptosis in cancer cells by inhibiting kinases that are critical for cell survival and proliferation. This compound has been shown to be effective against various types of cancer in both Chinese hamster ovary and human cancer cell lines. Additionally, it has been found to increase the excretion of the anti-allergic drug rupatadine in urine. The use of 1,8,15,22-Tetrazacyclooctacosane-2,7,16,21-tetraone as a tumor inhibitor has also been investigated in combination with other kinase inhibitors such as bendamustine analogs. This compound holds great potential for the development of new anticancer therapies.
Chemical properties
Technical inquiry about: 3D-EAA23835 1,8,15,22-Tetrazacyclooctacosane-2,7,16,21-tetraone
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
